Clik here to view.
Immunocore and Pulse Infoframe, Inc. Partner with Leading Academic...
OXFORD, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md. & ONTARIO, Canada Immunocore Limited, a leading T cell receptor biotechnology company, and Pulse Infoframe, Inc. (Pulse), a data...
View ArticleClik here to view.
Gain Therapeuticsが有効な応募325件中2位の評価を得て、生物医学研究所およびNeuro-Sys...
スイス・ルガーノ & スイス・ベリンツォーナ & 仏ガルダンヌ （ビジネスワイヤ） — 代謝異常と中枢神経系（CNS）疾患の先天異常に関与するリソソーム酵素を標的とする新規治療薬の創薬と開発に取り組むバイオテクノロジー企業のGain Therapeutics...
View ArticleClik here to view.
Clik here to view.
CANbridge Pharmaceuticals Submits New Drug Application for Hunterase® for the...
BEIJING & SHANGHAI CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced...
View ArticleClik here to view.
Clik here to view.
Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License...
ALAMEDA, Calif. Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited...
View ArticleClik here to view.
Clik here to view.
EdiGENE Changes Name to Modalis Therapeutics
TOKYO & CAMBRIDGE, Mass. EdiGENE Corporation today announced that the company has changed its name to Modalis Therapeutics Corporation. Modalis (pronounced “MO-DA-LIS”) is an original name that...
View ArticleClik here to view.
ITM and DCB Sign Exclusive Licensing & Development Agreement for Solucin® TRT...
MUNICH & GARCHING, Germany ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemBio Co, Ltd. (DCB), a leading Korean...
View ArticleClik here to view.
CANbridge Pharmaceuticals’ Hunterase® Granted Priority Review by the Chinese...
BEIJING & SHANGHAI CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced...
View ArticleClik here to view.
Genome Editing Biotech EdiGene Raises $11 M in Series Pre-B2 Financing and...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery,...
View ArticleClik here to view.
Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology
SEOUL, South Korea The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com) announced on September 17 that it had been granted a U.S. patent for its...
View ArticleClik here to view.
SanBio Granted Regenerative Medicine Advanced Therapy Designation from the...
MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological disorders, today announced that the U.S. Food...
View ArticleClik here to view.
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program...
WILMINGTON, Del. Incyte (Nasdaq:INCY) today announced that the first patient has been treated in the Phase 3 TRuE-V clinical trial program evaluating the safety and efficacy of ruxolitinib cream as...
View ArticleClik here to view.
インサイト、白斑患者でルキソリチニブ・クリームを評価する第3相臨床試験プログラムで最初の患者が治療を受けたと発表
米デラウェア州ウィルミントン （ビジネスワイヤ） — インサイト（Nasdaq:INCY）は本日、第3相TRuE-V臨床試験プログラムで最初の患者が治療を受けたと発表しました。本プログラムは、白斑の青年・成人患者（年齢12歳以上）に対する単剤療法としてのルキソリチニブ・クリームの安全性と有効性を評価するものです。...
View ArticleClik here to view.
CAP Laboratory Accreditation Program Expands Inspector Training Footprint in...
TOKYO The College of American Pathologists (CAP) and CGIkk hosted laboratory accreditation inspector training for 20 pathologists from leading institutions across Japan. The September 28 training...
View ArticleClik here to view.
CAP検査室認定プログラムが日本で審査員研修の参加機関を拡大
東京 （ビジネスワイヤ） — 米国病理医協会（CAP）とCGIkkは、日本の有力機関に所属する病理医20人を対象とする検査室認定審査員研修を開催しました。9月28日の研修は、CAPに代わって検査室を認定する審査員を地域でさらに増やし、検査室の質と正確性を確保して患者ケアを改善する上で、最初の取り組みとなります。...
View ArticleClik here to view.
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy...
MALVERN, Pa, & TIANJIN, China Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on innovative therapies that address rare and underserved eye diseases, has entered...
View ArticleClik here to view.
SIRION Biotech to Participate in Major International Industry Conferences
MARTINSRIED, Germany SIRION Biotech GmbH (“SIRION”) today announced its participation in major international conferences this October. SIRION, offering the most comprehensive portfolio of custom...
View ArticleClik here to view.
Kraig Biocraft Laboratories COO Travels to Vietnam to Assist Transition of...
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that Jon Rice, the Company’s chief operating officer,...
View Article